Tango Therapeutics Inc (TNGO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,786 | -2,284 | 252 | 2,936 | 265 |
| Depreciation Amortization | 7,459 | 4,766 | 2,196 | 10,223 | 7,729 |
| Income taxes - deferred | 528 | 356 | 131 | 989 | 733 |
| Accounts receivable | -4,768 | -1,215 | -2,002 | -14,283 | -9,167 |
| Accounts payable and accrued liabilities | 1,206 | -1,194 | -1,120 | 1,595 | -204 |
| Other Working Capital | -2,495 | -2,114 | -3,709 | -13,400 | -11,250 |
| Other Operating Activity | 17,977 | 12,413 | 8,253 | 31,486 | 24,098 |
| Operating Cash Flow | $13,121 | $10,728 | $4,001 | $19,546 | $12,204 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,804 | -1,800 | -794 | -3,569 | -2,699 |
| Net Acquisitions | -22,541 | -22,000 | N/A | -881 | -881 |
| Investing Cash Flow | $-25,345 | $-23,800 | $-794 | $-4,450 | $-3,580 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 608 | 583 | 0 | 177 | 177 |
| Debt Repayment | -1,578 | -937 | -226 | -858 | -658 |
| Common Stock Issued | 855 | 747 | 665 | 2,100 | 1,897 |
| Common Stock Repurchased | -2,000 | -2,000 | -2,000 | -7,915 | -4,000 |
| Financing Cash Flow | $-2,115 | $-1,607 | $-1,561 | $-6,496 | $-2,584 |
| Exchange Rate Effect | -381 | -179 | -382 | -503 | -304 |
| Beginning Cash Position | 51,279 | 51,279 | 51,279 | 43,182 | 43,182 |
| End Cash Position | 36,559 | 36,421 | 52,543 | 51,279 | 48,918 |
| Net Cash Flow | $-14,720 | $-14,858 | $1,264 | $8,097 | $5,736 |
| Free Cash Flow | |||||
| Operating Cash Flow | 13,121 | 10,728 | 4,001 | 19,546 | 12,204 |
| Capital Expenditure | -2,804 | -1,800 | -794 | -3,569 | -2,699 |
| Free Cash Flow | 10,317 | 8,928 | 3,207 | 15,977 | 9,505 |